Welcome to the European Association for Cancer Research
Connecting cancer researchers together
EACR-AstraZeneca Conference: Circulating Nucleic Acids (cfDNA/ctDNA): In use, in view and on the horizon
Virtual Event, Worldwide : 28 - 29 January 2025
Scientific programme
To download and print the programme, use the links below.
Listed times are in Central European Time (CET)
WELCOME TO DAY ONE
Opening words: James Hadfield
Session 1: Horizons for Liquid Biopsy
Session Chair: James Hadfield
KEYNOTE LECTURE
Yuval Dor Hebrew University of Jerusalem, Jerusalem, Israel
Q&A 13:25-13:40
Viktor Adalsteinsson Gerstner Centre for Cancer Diagnostics, Broad Institute, Cambridge, USA
Priming agents transiently attenuate cfDNA clearance to improve liquid biopsies
Q&A 14:00-14:15
Davina Gale AstraZeneca, Cambridge, UK
Q&A 14:35-14:50
REFRESHMENT BREAK
Session 2: Liquid biopsies for breast and lung cancers
Session Chair: Davina Gale
Heather Parsons Dana-Farber Cancer Institute, Boston, USA
Q&A 15:25-15:40
Proffered Paper 1
Q&A 15:50-15:55
Proffered Paper 2
Q&A 16:05 - 16:10
Max Diehn Stanford University School of Medicine, Stanford, USA
Liquid biopsies for detection and characterization of lung cancers
Q&A 16:30-16:45
POSTER SPOTLIGHTS
TRANSITION BREAK
VIRTUAL POSTER SESSION ONE
Listed times are in Central European Time (CET)
VIRTUAL POSTER SESSION TWO
TRANSITION BREAK
WELCOME TO DAY TWO
Session 3: Liquid biopsy in colorectal and bladder cancers
Session Chair: Evi Lianidou
Naureen Starling The Royal Marsden NHS Foundation Trust, London, UK
Circulating nucleic acids (cfDNA/ctDNA): in use, in view and on the horizon’ a GI perspective but with broader applicability
Q&A 14:25-14:40
Silvia Marsoni IFOM, Milan, Italy
'Leveraging liquid biopsy to deconvolute colon cancer biology'
Q&A 15:00-15:15
Lars Dyrskjøt Aarhus University. Aarhus, Denmark
Towards ctDNA-guided treatment of muscle-invasive bladder cancer
Q&A 15:35-15:50
REFRESHMENT BREAK
Session 4: Next generation liquid biopsy researchers
Session Chair: Caroline Dive
Proffered Paper 3
Q&A 16:15-16:25
Proffered Paper 4
Q&A 16:35-16:45
KEYNOTE LECTURE
Victor Velculescu Johns Hopkins University School of Medicine, Baltimore, USA
Q&A 17:05-17:20
DISCUSSION SESSION
Clinical implementation and new technologies
Silvia Marsoni (Chair), IFOM, Milan, Italy; James Hadfield, AstraZeneca, Cambridge, UK; Davina Gale, AstraZeneca, Cambridge, UK
SUMMARY AND CLOSE
